Transl Gastroenterol Hepatol
Dr. Ziad Abuhelwa, MD
NPI1972113298
- Part D claims, 2024
- 40
- Publications
- 33
- Hospital affiliations
- 1
- Industry payments
- $261
- State licenses
- 2
- Practice address
- 12902 Magnolia Dr, Tampa, FL 33612
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Abuhelwa's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Ziad Abuhelwa is a hematologist and oncologist in Tampa, Florida
Dr. Abuhelwa practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.
Dr. Abuhelwa's NPI, 1972113298, was assigned on August 1, 2020. Dr. Abuhelwa graduated from University of Toledo College of Medicine and Life Sciences in 2023. Dr. Abuhelwa holds Florida license TRN37374.
NPI and contact details
- NPI
- 1972113298NPI Registry (opens in a new tab)
- NPI enumeration date
- August 1, 2020
- NPI status
- Active
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 2023
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Ziad Abuhelwa practices at Moffitt Cancer Hospital in Tampa, Florida
Dr. Abuhelwa's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.
- Moffitt Cancer Hospital12902 Magnolia Dr, Tampa, FL 33612
Source: Dmand AI Affiliation Data
Dr. Ziad Abuhelwa is affiliated with 1 site of care
Dr. Abuhelwa's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Ziad Abuhelwa's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abuhelwa practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Moffitt Cancer Hospital | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Abuhelwa practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Moffitt Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Ziad Abuhelwa is one of 693 hematologists and oncologists in Florida
Hematology and oncology is Dr. Abuhelwa's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Abuhelwa is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Abuhelwa's licenses on file in 2 states: Florida and Ohio.
Specialties and state licenses
- Hematology and oncology, FloridaPrimary
- Ohio license
Hematologists and oncologists near Dr. Abuhelwa
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
693hematologists and oncologists in Florida84hematologists and oncologists in Tampa59hematologists and oncologists at Moffitt Cancer Hospital
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Ziad Abuhelwa's patients have a median age of 62
Across all payers, Dmand AI patient panel data puts Dr. Abuhelwa's median patient age at 62, with 59% women.
Dr. Abuhelwa's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 62
Patient panel by sex, all payers
- Women59%
- Men40%
Source: Dmand AI Patient Panel Data
Dr. Ziad Abuhelwa wrote 40 Medicare Part D claims in 2024
In 2024, Dr. Abuhelwa wrote 40 Medicare Part D claims for 17 patients. 48% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $148 in total drug cost. In 2022, CMS named 43 claims across 3 drugs.
Part D claims, 202440
Drugs named by CMS2
Total drug cost$148
Part D patients17
Dr. Abuhelwa's Part D claims by kind of drug, 2024
- Generic19 claims48%
- Brand-name21 claims53%
Dr. Abuhelwa's most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2023
- 2022
- 2023
- Claims for drugs CMS names
- 2022: 432023: 2640%
Drugs named by CMS: 2 in 2023, 3 in 2022.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Abuhelwa by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Ziad Abuhelwa has 33 publications on record
Dmand AI links 33 papers to Dr. Abuhelwa, published from 2017 to 2025. 2022 was the busiest year, with 15. The most frequent topics are Antibodies, Monoclonal, Antineoplastic Agents and Antineoplastic Combined Chemotherapy Protocols. Dr. Abuhelwa has published most often in Am J Ther. Dr. Abuhelwa's most frequent co-authors are Ragheb A. Assaly, MD, Waleed Shaheen Khokher, MD and Cameron J. Burmeister, MD.
Papers33
Years published2017 to 2025
Dr. Abuhelwa's papers by year, 2017 to 2025
Topics Dr. Abuhelwa writes about most
- Antibodies, Monoclonal
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- Carcinoma, Non-Small-Cell Lung
- Immunoconjugates
- Lung Neoplasms
- Multiple Myeloma
- Proton Pump Inhibitors
Dr. Abuhelwa's most frequent co-authors
- Ragheb A. Assaly, MD15 shared papers
- Waleed Shaheen Khokher, MD9 shared papers
- Cameron J. Burmeister, MD6 shared papers
Recent publications by Dr. Abuhelwa
Antibodies, MonoclonalAntineoplastic Combined Chemotherapy ProtocolsMultiple Myeloma
BortezomibDrug-Related Side Effects and Adverse ReactionsLenalidomide
MidodrineRandomized Controlled Trials as TopicShock
See who Dr. Abuhelwa researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Abuhelwa works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Ziad Abuhelwa received $261 in industry payments in 2025
CMS Open Payments shows 2 general payments to Dr. Abuhelwa from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $135.
Companies that paid Dr. Abuhelwa the most, 2025 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Ziad Abuhelwa graduated from University of Toledo College of Medicine and Life Sciences
Dr. Abuhelwa graduated from University of Toledo College of Medicine and Life Sciences in 2023.
- Medical school
- Board certified in internal medicine
Source: Dmand AI Professional Profile Data
Sources for Dr. Ziad Abuhelwa's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Ziad Abuhelwa
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Ziad Abuhelwa's NPI number?
Dr. Ziad Abuhelwa's NPI number is 1972113298. It was assigned on August 1, 2020, and it is active in the NPI Registry.
What kind of doctor is Dr. Ziad Abuhelwa?
Dr. Ziad Abuhelwa is a hematologist and oncologist in Tampa, Florida. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Ziad Abuhelwa practice?
Dr. Abuhelwa practices at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Abuhelwa's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.
What is Dr. Ziad Abuhelwa's medical license number?
Dr. Abuhelwa holds Florida license TRN37374, one of the licenses on file in 2 states.
Which states has Dr. Ziad Abuhelwa been licensed in?
Dmand AI has state licenses on file for Dr. Abuhelwa in Florida and Ohio (2020 to 2023).
Which hospitals is Dr. Ziad Abuhelwa affiliated with?
Dr. Abuhelwa practices at Moffitt Cancer Hospital in Tampa, Florida.
Is Dr. Ziad Abuhelwa board certified?
Yes. Dr. Abuhelwa is board certified in internal medicine by the American Board of Internal Medicine.
Where did Dr. Ziad Abuhelwa go to medical school?
Dr. Abuhelwa graduated from University of Toledo College of Medicine and Life Sciences in 2023.
What drugs does Dr. Ziad Abuhelwa prescribe most?
In 2023 Medicare Part D data, Dr. Abuhelwa's most prescribed drugs by claims were Atorvastatin Calcium and Amlodipine Besylate.
Has Dr. Ziad Abuhelwa received payments from drug or device companies?
CMS Open Payments shows $261 in general payments to Dr. Abuhelwa from 2 companies from 2025 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
Show 3 more questionsShow fewer questions
How long has Dr. Ziad Abuhelwa been practicing?
Dr. Abuhelwa graduated from medical school in 2023, 3 years ago.
Does Dr. Ziad Abuhelwa do research?
Dmand AI links 33 publications to Dr. Abuhelwa, published from 2017 to 2025.
Who does Dr. Ziad Abuhelwa publish with?
Dr. Abuhelwa's most frequent co-authors are Ragheb A. Assaly, MD (15 shared papers), Waleed Shaheen Khokher, MD (9 shared papers) and Cameron J. Burmeister, MD (6 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card